Europe Antibiotics (Cephalosporin, Penicillin) Market Trends Analysis Report 2024-2030: Generic Antibiotics Dominate Supported by Regulatory Framework, Branded Antibiotics to Witness Rapid Growth
11 avr. 2024 11h19 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Europe Antibiotics Market Size, Share & Trends Analysis Report by Drug Class (Cephalosporin, Penicillin), Type (Branded Antibodies, Generic...
Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain
07 mars 2024 03h00 HE
|
Persica Pharmaceuticals
Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held,...
Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of Inhalational Anthrax, Triggering Additional Procurement under BARDA Project BioShield Contract
05 mars 2024 06h45 HE
|
Paratek Pharmaceuticals, Inc.
Paratek Announces Positive Efficacy Data for NUZYRA®, Triggering Additional Procurement under BARDA Project BioShield Contract
Biopharmaceutical Fermentation Systems Market Projected to Reach USD 52.6 billion by 2031, with a CAGR of 9.5%: Report by Transparency Market Research Inc.
01 mars 2024 01h32 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 01, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global biopharmaceutical fermentation systems market is projected to grow at a CAGR of...
Chronic Obstructive Pulmonary Disease Treatment Market revenue to cross USD 22 Billion by 2036, says Research Nester
29 févr. 2024 07h30 HE
|
Research Nester
New York, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease (COPD) treatment market size is estimated to attain at ~9% CAGR from 2024 to 2036. The market is expected...
Daptomycin Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Teva Pharma, Merck, Cipla, Pfizer, BE Pharmaceuticals, Reddy's Laboratories, and Mylan
20 févr. 2024 09h57 HE
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Daptomycin Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6
20 févr. 2024 04h00 HE
|
AKAMPION
- Designation underlines the need for novel, first-in-class antimicrobials for the treatment of infections with Gram-negative bacteria JERUSALEM, Israel, February 20, 2023 -- Omnix Medical, a...
Metronidazole Market Forecast to 2032: Highlights Trends and the Competitive Landscape in CDI Treatment
30 janv. 2024 06h44 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Metronidazole Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This insightful report provides...
Vancomycin Drug Insights and Market Forecast to 2032 for Clostridium Difficile Infection Treatment in Key Global Regions
29 janv. 2024 12h38 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Vancomycin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report presents an in-depth...
Global Antibacterial Drugs Market Projected to Exceed $39 Billion by 2024 Amidst Challenges and Innovations
25 janv. 2024 10h40 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Antibacterial Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for the antibacterial drugs market...